THE IMPACT OF ANTI-TNF-THERAPY ON ENDOTHELIAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS

被引：1
|
作者：
Heinz, K. [1 ]
Oelzner, P. [1 ]
Eidner, T. [1 ]
Goetze, K. [1 ]
Saemann, A. [1 ]
Wolf, G. [1 ]
Neumann, T. [1 ,2 ]
机构：
[1] Jena Univ Hosp, Internal Med 3, Jena, Germany
[2] Kantonsspital St Gallen, Rheumatol, St Gallen, Switzerland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.4734
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0072
引用
收藏
页码：582 / 582
页数：1
相关论文
共 50 条
  • [1] METHOTREXATE AND ANTI-TNF TREATMENT IMPROVE ENDOTHELIAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Deyab, G.
    Hokstad, I.
    Smastuen, M. C.
    Agewall, S.
    Hollan, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 704 - 704
  • [2] PERSISTENCY WITH SUBCUTANEOUS ANTI-TNF THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Waters, H.
    Olson, W.
    Bolge, S.
    Gunnarsson, C.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A41 - A41
  • [3] Discontinuation of Methotrexate or TNF Inhibitors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    George, Michael D.
    Baker, Joshua F.
    Ogdie, Alexis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] Golimumab: a new anti-TNF-α agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    Voulgari, Paraskevi V.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 721 - 733
  • [5] Methotrexate and Anti-Tumor Necrosis Treatment Improve Endothelial Function in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
    Deyab, Gia
    Hokstad, Ingrid
    Agewall, Stefan
    Lyberg, Torstein
    Whist, Jon Elling
    Smastuen, Milada Cvancarova
    Hjeltnes, Gunnbjorg
    Hollan, Ivana
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] THREE TNF-A-INHIBITORS FOR TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS
    Ivakhnenko, O.
    Rebrova, O.
    Avxentyeva, M.
    Khachatryan, G.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A564 - A564
  • [7] Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis
    Haberhauer, Guenther
    Strehblow, Christoph
    Fasching, Peter
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (9-10) : 220 - 224
  • [8] Effects of anti-TNF therapy on glucose metabolism in patients with ankylosing spondylitis, psoriatic arthritis or juvenile idiopathic arthritis
    Pires da Silva, Barbara Santos
    Bonfa, Eloisa
    Bertacini de Moraes, Julio Cesar
    Schain Saad, Carla Goncalves
    de Medeiros Ribeiro, Ana Cristina
    Goncalves, Celio Roberto
    de Carvalho, Jozelio Freire
    [J]. BIOLOGICALS, 2010, 38 (05) : 567 - 569
  • [9] ANTI-TNF-THERAPY REDUCES UVEITIS FLARES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Godzenko, A.
    Botchkova, A.
    Rumyantceva, O.
    Erdes, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 945 - 945
  • [10] ETANERCEPT RETENTION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS
    Dongen, C. V.
    Kneepkens, E.
    Vogelzang, E.
    l'Ami, M.
    Krieckaert, C.
    van der Horst, I.
    Voskuyl, A.
    Nurmohamed, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1145 - 1145
12345